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Abstract: We conducted a scoping review of literature to improve our understanding of the accuracy
of infectious disease monitoring in migrants in the Europe. We searched PubMed for papers relevant
to the topic including: case reports, observational and experimental studies, reviews, guidelines or
policy documents; published after 1994. We identified 532 papers, 27 of which were included in
the review. Legislation and right to access health care influence both the accuracy of rates and risk
measures under estimating the at risk population, i.e., the denominator. Furthermore, the number
of reported cases, i.e., the numerator, may also include cases not accounted for in the denominator.
Both biases lead to an overestimated disease occurrence. Restriction to healthcare access and low
responsiveness may cause under-detection of cases, however a quantification of this phenomenon
has not been produced. On the contrary, screening for asymptomatic diseases increases ascertainment
leading to increased detection of cases. Incompleteness of denominator data underestimates the
at-risk population. In conclusion, most studies show a lower probability of under-reporting infectious
diseases in migrants compared with native populations.
Keywords: migrant health; infectious diseases; surveillance; under-reporting
1. Introduction
Migration is a heterogeneous phenomenon in Europe. At the beginning of the 20th century,
many European countries saw large sections of their population emigrating both within and outside
the current European Union (EU). This trend has changed over time with a growing number of EU
countries becoming recipients of immigrants. Therefore, in the EU, there are countries with a long
history of migration and others in which this is a recent phenomenon [1].
Some EU countries experience the effects of periodic exceptional inflows of new economic
migrants or asylum seekers. Conversely, in other EU countries, migrants and their descendants
have, over time, acquired a demographic and social stratification that might make their health profile
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closer to that of the host population [2]. As a result, the foreign-borne population between and within
European countries is diverse in terms of countries of origin and length of stay.
Migrants arriving to the EU are generally in good health [3]. This is due to several factors, such as
good pre-travel health status and the fact that most infectious diseases have much shorter incubation
periods than the time required to journey across the recognized Mediterranean migration routes.
Notwithstanding, travelling conditions might make some migrants more vulnerable to health threats,
due to exposures before arriving to the EU combined with low vaccination coverage. There is also
evidence that migrants arriving and living in the EU and in the European Economic Area (EEA) are
vulnerable to the negative effects on health of poor socio-economic living conditions [3].
EU/EEA Member States notify infectious diseases through a binding legal framework that defines
a common standard for epidemiological surveillance [4–6]. However, concerns have been raised
regarding the capacity of the existing surveillance systems to effectively monitor the health of migrant
populations in the EU/EEA, and in particular infectious diseases [1,3,7,8]. A recent and extensive
analysis of statutory infectious disease surveillance data in the EU/EEA, failed to draw overall
conclusions about infectious disease burden among migrant populations in the EU/EEA [3] due to
data limitations and differences in reporting between countries. A subsequent article [1] highlighted
that these statutory surveillance systems lack variables to stratify cases of an infectious disease among
migrant populations according to factors associated with an increased risk of contracting it. This in
turn makes it difficult to interpret time trends and to identify which migrant population groups are
most affected. In addition, syndromic surveillance systems targeting epidemic prone diseases have
been developed alongside statutory systems to increase early detection and response capacities in
countries experiencing large sudden influxes of migrants [9,10]. These parallel information sources,
although timely, collect aggregated information on combinations of clinical signs and symptoms
(i.e., syndromes) ahead of diagnosis and therefore cannot be imported into case-based, clinical and
laboratory, national and EU surveillance systems [1].
Three aspects are particularly relevant when addressing the issue of monitoring infectious diseases.
Firstly, almost all our monitoring systems, particularly those focusing on infectious diseases, are based
on the notification of identified cases of disease and other health related events (i.e., vaccination,
infection status) that are diagnosed or occur only when a person has contact with the health services.
Therefore, access to health services strongly influences any attempt to monitor the health status
of a specific population. For a migrant, the probability of accessing health services is obviously
influenced by the country legislation and the right for migrants to access health care, which could be
different according to their legal status (i.e., regular, irregular, asylum seeker and all the other different
conditions that the administrative system can distinguish). However, health system accessibility is
also influenced by factors not directly linked to the laws regulating the right to access. These include:
the affordability of the system (i.e., if it is free or not, if insurance is needed) and the responsiveness of
health services (i.e., if mediators or language interpreters are available, accessibility of the clinics etc.)
(Figure 1, bottom left part) [11].
Differential access to the health system could also change the probability of acquiring an infectious
disease. For example, primary prevention in the case of vaccination or early treatment of contagious
individuals/prophylaxis of contacts leads to the prevention of secondary cases (Figure 1, top left part).
Secondly, there are different screening policies for infectious diseases targeting newly arrived
migrants in the majority of EU/EEA countries [12] and in several non-EU countries in the
Mediterranean Basin and Black Sea Regions [13]. In most countries, all newly arrived migrants
or some specific subgroups undergo screening for tuberculosis (TB) [14–17], systematically increasing
the probability of diagnosing the disease and/or latent infections (Figure 1, centre).
Thirdly, most of the indicators in a monitoring system need an accurate estimate of the at risk
population, i.e., the denominator of the incidence and prevalence measures, to compare results
in different geographic areas or in time (trends) and to allow meaningful interpretations of data.
Knowing the immigrant population at risk has been recognised as a major problem in the field of
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migrant infectious disease epidemiology by the European Commission [5]. In fact, it is always difficult
to understand if a reported case is included in the available denominators or not. This is even more
difficult with respect to irregular migrants (Figure 1, right part).
According to these considerations, we conducted a scoping review [18] to identify the factors
influencing the accuracy of infectious disease monitoring in migrants in the EU/EEA.
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Figure 1. Interaction between migrant access to health care and indica ors to monitor infectious
diseases. In the middle, the theoretical flow from occurrence of the disease to reporting the event in
a surveillance system is repres nte . Black arrow represent the causal effects of factors that could
influence the probability of occurrence of the disease, access to health service, diagnosis, reporting,
and computing a correct indicator of infectious diseases in migrants.
2. Methods
2.1. Mapping the Scoping Review
Given the broad spectrum of possible mechanisms involved and the unknown number of factors
acting through these mechanisms, we decided to conduct a scoping review. This kind of review allows
identifying all the possible issues even if it will not give a systematic quantification of the effects.
The choice of not giving quantita ive effects is also justified because t magnitude of surveillance
inaccuracy is country, time and disease specific [3], making the attempt to give a quantitative estimate
not useful, while the under yi g mec anis s can be commo .
We based our study design on previous European Centre for Disease Prevention and Control
(ECDC) technical documents [3,19–25], on migrant health and infection, that were also based on
scoping review studies [1].
We defined “Migrants” as persons, and family members, moving to another country or region
to better their material or social conditions and improve the prospect for themselves or their family
following the definition of the International Organization for Migration (IOM) [26].
After a preliminary search of the meta-literature, we designed a conceptual framework (Figure 1).
This framework illustrates the process from the occurrence of the health problem to the reporting in a
surveillance system, and all the factors that can differentially influence this process in the immigrant
population compared to the native population.
The framework helped us to identify specific questions to formulate the PICOs (Population,
Intervention, Comparison, Outcome) for the literature search. Thus the scope of this literature review
can be summarized in the following questions:
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• Which are the possible barriers in access to health services that cause under-diagnosis and other
mechanisms that can affect the number of reported events (under-reporting, over-reporting,
biases in reporting).
• What are the key issues with respect to the definition of the at risk population, i.e., the denominator,
and how they affect the accuracy of infectious disease occurrence indicators in migrants and their
comparability with indicators in native populations.
• How can screening programs for infectious diseases targeting newly arrived migrants introduce
bias in event reporting.
2.2. Eligibility Criteria and Search Strategy
Articles were considered for inclusion if they: (i) were case report studies, descriptive and analytic
observational studies, experimental studies, reviews, systematic reviews and meta-analysis, guidelines
or policy documents (published and unpublished); (ii) were published after 1994; (iii) were published
in English, French, Spanish, German or Italian; (iv) included data on infectious diseases; (v) included
data from the EU/EEA. For misreporting and denominator, we decided to include also papers from
Australia, New Zealand, Canada and United States, because these topics are not frequently treated by
the literature and because they are the most methodological issues and less likely to be influenced by
local peculiarities.
Three independent literature searches were conducted in PubMed, using both free text
and Medical Subject Heading (Mesh) terms: one for the misreporting issues (under-reporting,
over-reporting and biases in reporting); one for the denominator-related issues; and one for the
effect of screening on reporting accuracy.
The literature searches for misreporting and denominator were performed on 14 March 2014;
the literature search for screening was performed on 17 March 2014, all records included in PubMed
up that date were included.
The literature search strategies are presented in Supplementary Figures S1 and S2. Limiting the
search to PubMed was considered adequate for this scoping review because it is aimed at identifying
all the topics that are relevant for accuracy, but with the awareness that a precise quantification of this
effect is not possible since it would be time, place, disease and population specific.
2.3. Study Selection and Data Collection Process
Eligibility assessment for inclusion was performed independently by two reviewers, initially by
screening of all identified papers and reports based on title and abstract, excluding irrelevant papers,
i.e., not mentioning accuracy or accuracy-related issues. All relevant articles were obtained in full text.
2.4. Data Extraction and Synthesis
At the end of the search, the full texts were analyzed extrapolating the information about the
study population (regular or irregular immigrant, refugee), the country, the health problem or diseases
(see Supplementary Table S1). For all the papers, a narrative synthesis of the results was made.
Efforts were made to make a synthesis of all the issues mentioned in the original papers. In some
papers, a quantification of the inaccuracy (mostly under-reporting) was reported for migrant and
native populations, allowing a comparison and sometimes an understanding of the determinants of
the observed differences. In some cases, the objective of the included papers was not to assess the
inaccuracy of reporting or explore its determinants, thus in these papers there were no explicit results
but only reported indirect evidence of inaccuracy. In other cases, under-reporting was considered as
a possible bias of the study and thus was only reported in the limitations section of the discussion
without any quantitative assessment. Therefore, the results found in each paper were classified in three
categories according to the grade of evidence reported: evidence of presence/absence of differential
bias in reporting for immigrants and native population and sound quantification of this bias; evidence
of differential bias but not quantifiable; hypothesis of presence/absence of differential bias in reporting.
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3. Results
3.1. Synthesis of the Literature Results: Misreporting
After search and selection, 16 papers were included, nine European and seven from other
industrialized countries (Supplementary Figure S3). The studies covered the following diseases:
tuberculosis (six articles); HIV and/or AIDS (two); hepatitis B or C (three); tuberculosis and HIV (one);
pertussis (one), opportunistic infections (one), septic arthritis (one) and bacterial meningitis (one).
Twelve articles focused on diagnosis; two on prevention; one on prevention, diagnosis and treatment
and one on aspects unrelated to the phases of health care (i.e., self-reported health data). Four main
issues were identified: over-reporting, under-reporting, other issues in accuracy of reporting, methods
for surveillance.
3.1.1. Possible Decrease of Under-Reporting
Four articles [27–30] reported less under-reporting in migrants than in the native population.
In particular Melosini and coll [27], in a study conducted at a University Hospital in Central Italy, found
lower TB under-reporting in migrants than in native Italians (18% of unreported cases in migrants
vs. 68% in natives (p < 0.001); the authors could not explain this difference. Farchi and coll [29]
found a reduction of TB under-reporting in the most recent period and a stronger improvement of
TB surveillance among migrants (at the end of the period the unreported cases were 19% vs. 31% in
natives). Nightingale and coll [28] suggested lower under-reporting of hepatitis B and C infection in
migrant compared with native children, probably due to screening targeting newly arrived migrants.
Finally, using a capture-recapture model, Giorgi Rossi and coll [30] found that being a migrant increased
the probability of reporting bacterial meningitis.
3.1.2. Possible Increase of Under-Reporting
Jelastopulu and colleagues [31], describing TB incidence in western Greece, consider that over
recent years there has been uncontrolled illegal migration from high TB endemic regions to many
European countries, including Greece. The authors report that the majority of these migrants do not
usually undergo any tuberculosis control programs and that possible cases among migrants are less
likely to be diagnosed. They conclude that this could contribute to an underestimation of the disease
burden. The authors did not perform any analysis of under-reporting in migrant populations, but only
hypothesize this issue in the discussion.
Cohen et al. [32], in a Letter to the Editor, presented a chronic hepatitis B prevalence estimate in
the USA, including high prevalence rates in migrant populations. The authors estimated the current
burden of chronic hepatitis B in the USA to be approximately two million people. They concluded
that an underestimation of the true number of infected individuals in the USA has occurred, mostly
because the highest-at-risk populations are under-represented in surveillance studies, and a large
percentage of chronically infected individuals remain undiagnosed.
Wohl et al. [33] discussed the under-reporting that may result from the use of English-based criteria
for assessing mental status in the diagnosis of HIV encephalopathy among Spanish-speaking patients.
Somerville et al. [34] found that infant pertussis hospitalisation rates in New Zealand are three to
six times greater than rates in the USA, England and Australia. The hospitalisation rate varied with
ethnicity, being higher for Maori and Pacific populations compared with European/other. The authors
concluded that pertussis is under diagnosed, and consequently under-reported, in New Zealand,
and that this phenomenon varied with ethnicity.
3.1.3. Other Issues in Reporting Accuracy
Two articles [35,36] focused on underestimation mostly as a confounder, with no clear mention
of differential under-reporting by race/ethnicity. Ashrani and coworkers [35] addressed septic
arthritis in males with haemophilia in the USA. The authors found that, compared with Caucasians,
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Afro-Americans/Hispanics/persons of other ethnic groups were more likely to develop septic arthritis.
The authors suggest biological factors but also possible biases in diagnosis. Le Vu et al. [36] reported
population-based HIV-1 new infection incidence in France. In this country, HIV transmission
disproportionately affects certain risk groups. MSM (40%) were the most commonly diagnosed
during recent infection, compared with French-national heterosexual women (28%) and men (22%),
heterosexual non-French-national women (16%) and men (12%). The authors estimated under-reporting
for each group, but did not present this result.
Watkins and colleagues [37], studying prospective Vietnamese migrants who had applied to
migrate to Australia, found discrepancies between self-reported data collected in the confidential
interview and the medical screening for an Australian visa. The authors argued that these discrepancies
indicate that prospective migrant reports of health status and health behaviours may be biased by
expectations that unfavourable responses could adversely affect their chances of migration.
Porta et al. [38] and Winston et al. [39] reported the risk of misclassifying route of infection and
other exposures in HIV and TB, respectively [38,39]. Rose et al. [40] estimated the contribution of HIV
infection to the recent rise in TB in England and Wales. The authors concluded that as HIV infection
may be undiagnosed in patients with TB, and TB may be unreported in patients with diagnosed HIV
infection, the true extent of co-infection would have been underestimated and that this phenomenon
was stronger for some ethnic minorities.
3.1.4. Methods in Incidence/Prevalence Estimates
Three articles [29,41,42] aimed to calculate an unbiased infectious disease prevalence estimate for
the total population adjusting for high prevalence and including some risk groups, especially migrants,
which are usually under-represented in surveys.
Marschall et al. [41] aimed to calculate an adjusted prevalence of chronic hepatitis B estimate for
the total host population in The Netherlands, including migrants and other risk groups. These risk
groups were not well represented in a previous representative sero-surveillance study (from 1995),
which probably led to an underestimation of the true HBsAg prevalence.
Baussano and coworkers [42] aimed to assess the completeness of the TB registration systems
and estimation of TB incidence and under-reporting in a low-prevalence area (Piedmont Region of
Italy). Sensitivity of the notification system was estimated to be 77 (95% CI 74–79) for Italians and
migrants from low-prevalence countries and 86 (95% CI 81–90) for migrants from high-prevalence
countries. Farchi et al. [29] found 39% under-reporting of TB in another Italian region, Lazio. The
overall estimated TB incidence rate was 16.7 cases per 100,000 population (95% CI 16.3–17.3), varying
according to the subset investigated: 12.7 for individuals from low TB prevalence countries and
214.1 for migrants from high TB prevalence countries. The authors concluded that there are inaccurate
estimates of the annual incidence of TB, particularly among high-risk subsets of the population such
as immigrants from high TB prevalence countries.
3.2. Synthesis of the Literature Results: Denominators
Out of the four articles included, three were on TB and one on HIV, two European and two from
other industrialized countries (Supplementary Table S1).
Missing or Estimated Denominator Data
Farchi et al. ([29], initially extracted in the misreporting research) and Odone et al. [43] described
differences in diagnosed TB cases between foreign born and native populations in Italy. Both found
that the incidence in the foreign-born population is much higher than in the native-born population.
However, it was impossible to accurately estimate the incidence of TB, due to lack of a valid
denominator. In fact, residence permits are unanimously considered an underestimation of the
number of foreign people actually living in Italy because they do not include irregular migrants.
On the contrary, notified infectious diseases also include cases among irregular migrants. There is no
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way to distinguish between cases of disease among regular and irregular migrants on the basis of the
Italian statutory system for infectious disease surveillance. Odone et al. [43] tried to compute a TB
incidence rate taking into account an estimated 20% (10% in 2003) of not regularly registered migrants.
The authors admit that it is a very rough estimate as data on irregular migrants are unavailable.
In addition, by distinguishing cases on the basis of the country of birth, the authors could not include
young foreigners who were born in Italy in the migrant sub-group.
Das and colleagues [44], analysing the epidemiology of tuberculosis in New Zealand, explained
that for the calculation of the TB incidence rate by ethnicity, Statistics NZ prioritised an ethnicity
approach for both the numerator (reported cases) and denominator (at risk population). However,
it is possible that the numerator (surveillance data) and denominator (census data) were collected
differently. In the census, ethnicity recorded is self-identified. Hospital records are more frequently
coded with sole rather than multiple ethnicities. These practices create a numerator-denominator
mismatch, which cannot be eliminated.
Marc et al. [45] analysed HIV trends among Haitian-born persons in the United States. The authors
discussed the importance of having accurate denominators to estimate rates of new HIV infections
in the Haitian population. Using estimates from the 2007 American Community Survey, the results
suggested a seven-fold over-representation of Haitians in the CDC AIDS surveillance data. In contrast,
using denominator estimates from the Haitian Consulates, Haitian-born persons in the US, at this time,
had similar AIDS rates to African Americans overall, which challenges beliefs that Haitian immigrants
have a higher prevalence of AIDS than other groups.
3.3. Synthesis of the Literature Results: Screening
Nine papers included in the screening search tackled the issue of disease reporting inaccuracy
(Supplementary Table S1), eight were on TB while one article focussed on HBV and HCV.
Arshad and coll. [46], in a systematic review and meta-analysis of screening yield for TB, found
a higher yield for refugees than for regular migrants and for asylum seekers, probably because the
refugees are not self-selected to be healthy, i.e., no healthy migrant effect. The prevalence in migrants
was also found to be higher than the prevalence in their countries of origin. The authors suggested
that this could be due to problems of self-selection of high risk people among migrants. However,
over-reporting in screening or under-reporting in national statistics was also suggested to interpret
these results.
Pace-Asciak and coworkers [47] described the results of mandatory screening of TB at entry
point and subsequent surveillance of all migrants from 2002 to 2005 in Malta. The authors found a
very high TB prevalence at entry and cases with onset in the first months after entry. Surveillance
was found, however, to possibly overestimate incidence and prevalence because the total number of
undocumented migrants was under-estimated. Screening at entry was found not to reduce diagnostic
delay for cases diagnosed after entry. This suggests firstly that barriers to access services at community
level also exist when screening is offered free of charge. Secondly, that screening did not lead to
overestimating incidence per-se.
Verver et al. [48] found that TB cases detected through screening were less likely to be the first cases
of a cluster. The authors highlighted the risk of confounding with length of stay in The Netherlands,
that is shorter for screen-detected cases and influences the probability of infecting other people.
Erkens et al. [49] described the routine TB screening in The Netherlands for newly arrived
migrants, about 70,000 individuals followed for 29 months after arrival. The yield of screening was
high in the first year after arrival and related to the prevalence of disease in the country of origin
of migrants.
Fernández Sanfrancisco et al. [50] described the prevalence of TB infection in migrants from
different African countries at the Calamocarro refugee camp in Ceuta, Spain, and described
the mis-classification of old prevalent cases as incident cases in a cross-sectional study with
screening-like procedures.
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Pareek and colleagues [51] conducted a study on TB screening of migrants in UK. Considerable
heterogeneity and deviation from national guidance were found to exist throughout the UK new
entrant screening process. Screening for latent TB detected more cases than screening for active TB and
with high TB burden primary care centres undertaking the least screening and detecting fewer cases.
Kruijshaar et al. [52] found that TB incidence among immigrants in UK is not directly associated
to the prevalence of TB in origin countries. The authors suggest that this could also be due to different
screening policies at arrival.
Diel et al. [53], in an article on the epidemiology of TB in Hamburg, described that only a minority
of TB cases among migrants was found by screening asylum seekers and suggested no difference with
other migrants that are not routinely screened.
Nightingale et al. [28], in New South Wales, initially extracted in misreporting research, found
over-reporting of HBV infection for foreign children. In particular, most of the children with HBV
infection were found to be either refugees/migrants, or children of refugees/migrants. Since refugees
are often screened after arrival in Australia, the authors interpreted these results as due to an
ascertainment bias in this group.
Table 1 summarizes the main determinants of surveillance accuracy found in the literature search.
Table 1. Summary of results.
Issue Main Findings Type of Evidence References
Misreporting
Decrease
under-reporting
TB and meningitis are more often reported in
migrants Certain and quantified [27,29,30,42]
Improvement in TB surveillance was stronger
for immigrants Certain and quantified [29]
Increase under-reporting
Illegal immigrant could be under-diagnosed for TB Possible [31]
Lower response in surveys could under
represent immigrants Certain not quantified [32,41]
Language barriers decrease probability of
syndromic diagnoses Possible [33]
Under-diagnosis in minorities Possible [40]
Under-diagnosis in minorities Certain not quantified [34]
Other effects
Biases in systemic infection diagnosis Possible [35]
Biases in reporting information Possible [36,37]
Inaccuracy about the route of infection for TB
and HIV Certain not quantified [38,39]
Denominator
Under-estimation of the real at-risk population
for immigrants Certain not quantified [29,43]
People included in the numerator are not always
part of the denominator Certain not quantified [29,43–45]
Screening
Screening increases the probability of diagnosis Certain and quantified [28,46–49,51]
Misreporting of prevalent cases as incident Possible [50]
Screening modalities and implementation impact
on detection Certain and quantified [51]
Screening could leave less cases to be detected in
the routine surveillance Possible [52]
Screen-detected cases are less often first cases of
a cluster Certain and quantified [48]
Small effect on overall incidence Certain not quantified [53]
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3.4. Risk of Biases of the Included Papers
In this scoping review it was impossible to make a formal appraisal of the quality of studies and
probability of biases, because we focused on an aspect that was marginal for the authors of the original
studies. From the original paper authors’ point of view, misreporting was often only a possible source
of bias in measuring the association that was the main objective of their study. Indeed, some of the
papers included in the review only reported hypotheses on which unmeasured biases could affect their
estimates of disease occurrence in migrants and native population. We tried to categorise the quality
of evidence with an explicit grading. Out of 16 studies included in the search about misreporting,
four [27,29,30,42] reported evidence of a quantifiable inaccuracy of infectious disease reporting, three
reported an ascertained but not quantifiable inaccuracy of reporting [28,32,34], while the other nine
reported only a possible inaccuracy of reporting [31,33,35–41]. For the search about denominators all
four papers reported ascertained but not quantifiable inaccuracy of reporting [29,43–45]. Finally for
the search about screening, four papers reported an ascertained but not quantifiable inaccuracy of
reporting [28,46,48,49], while the other five reported only a possible inaccuracy of reporting [47,50–53]
(Table 1).
4. Discussion
4.1. Limits
The search strategies tried to identify all the papers reporting direct/indirect evidence or
hypotheses about factors affecting the accuracy of infectious disease reporting in migrants. Most of the
papers identified did not focus on our specific topic and only treated it as a possible bias of their results.
We cannot exclude that, in the search process, we missed some papers because the misreporting or the
biases were not mentioned in the title or abstract.
Even if the topic of the review is infectious diseases, we retrieved papers mostly on TB.
For screening, this cannot be considered a bias but simply reflects that TB is the only disease for
which there are guidelines recommending screening [14–17]. For the misreporting, this is actually a
limit of our review determined by the scarcity of literature on other diseases.
Only four papers were included in the search of the denominator-related issues. We cannot
exclude that other papers on migrant health, not specifically referring to infectious diseases,
have tackled the problem of estimating correct denominators, particularly of undocumented migrants,
with possibly interesting insights. Nevertheless, we decided to keep the search focussed on infectious
diseases because, to our knowledge, the infectious diseases surveillance systems are the only ones
in which non-resident migrants, regular or irregular, can be included in the numerator but not in
the denominator. The main source of inaccuracy of infectious disease occurrence in immigrants is
this peculiar mismatch between numerators and denominators that is not present in other health
information sources, such as mortality or hospitalization discharge, where the residence is well
reported in the numerators.
Only for the issues of misreporting and denominators we included in our search studies from
non-European industrialised countries. The problems emerged from non-European industrialised
countries were similar in the case of denominator: possible under-estimation of the true denominator
and mismatch of denominator and numerator. For the factors leading to misreporting, some authors
from non-European countries focussed on biases due to survey methods [32,33,35] or administrative
procedures [37] that are not commonly used in Europe.
Another limit of this review is that we considered the immigrants as single population, simplifying
the fact that they are a heterogeneous group characterised by different histories of migration, different
countries of origin and different length of stay in the host country. When evidence was available,
we highlighted in our findings whether the observations concerned newly arrived or immigrants with
any length of stay; immigrants from a specific country of origin or mixed populations. As the purpose
of this review was to provide an overall understanding of the drivers of over/under-reporting in
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migrant populations rather capture the entire complexity of the phenomenon, we do not think that
this simplification undermines the findings.
4.2. Main Findings
This review analysed several factors affecting the accuracy of reporting infectious disease in
migrants. Both factors favouring both under- and over-reporting were mentioned by the literature
(Table 1). Surprisingly, despite the a priori concern mostly being about the difficulty to detect and
report infectious diseases in migrants, most of the papers found evidence or insights pointing towards
lower under-reporting in migrants than in native populations [27–30].
The main factors contributing to this phenomenon are screening for infectious diseases in newly
arrived migrants, in particular for TB [28,46,47], and higher clinician attention to infectious diseases
when examining people with a history of migration [27,51]. Finally, difficulties in correctly estimating
the population at risk, in most cases, lead to an underestimation of the migrant population and
consequently to an overestimation of incidence and prevalence rates of infectious diseases [29,43,47].
On the other hand, the main reason for under-reporting has been linked to the barriers to health service
access experienced by many migrants [31,43]. Several authors pointed out that the most relevant
barrier for migrants to access to health services, and thus to infectious disease reporting, is the fear of
being identified as irregular, even when enjoying a regular status [37]. Figure 2 tries to put the findings
of this scoping review in the context of the conceptual framework we initially adopted.
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Figure 2. Results of the scoping review reported on the conceptual framework of the interaction
between migrant access to health care and indicators to monitor infectious diseases. In the middle
the theoretical flow from occurrence of the disease to reporting the event in a surveillance system is
represented. Black arrows represent the causal effects of factors that could influence the accuracy of
infectious disease surveillance in immigrants. The grey boxes report the results of the literature review.
Not all the possible effects found in the literature have the same level of evidence. In fact,
as reported in Table 1, in most cases factors determining an increased under-reporting in migrants are
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only theoretically hypothesized by the authors, while the factors determining lower under-reporting
in migrants, such as entry screening and higher attention in diagnosis and notification, have been
ascertained and, in some cases, also quantified. The other factor leading to an over-estimation of the
risk of disease in migrant compared to native, i.e., the under-estimation of the denominator and the
inclusion in the numerator of people that are not in the denominator, has also been ascertained.
4.3. Implication for Surveillance Practice
Our results can give some suggestions for improving existing surveillance systems and to design
a European network of surveillances:
• We should focus on improving the existing systems for native and migrant populations alike,
with specific attention to under reporting in native populations (in particular for TB and
meningitis). We believe this approach, as opposed to establishing special surveillance systems for
migrant populations, would provide a better picture of the actual epidemiology of these diseases.
• Surveillance systems should be better characterized, through the inclusion of specific surveillance
variables, the main risk factors for infectious diseases among migrants, i.e., country of
origin [46,49,51], length of stay [48], and history of migration [46,52] in order to better understand
the observed trends and plan public health interventions.
• Finally, some of the most relevant biases in estimating disease occurrence could be avoided
providing a certain indication about the presence or not of the case reported in the available
denominators for foreigners [29,43–45]. In most cases it would be sufficient to include a variable
on the resident status of the foreigner (i.e., if he/she is formally resident in the host country or
not, without any further assessment of regular or irregular state). This would allow to calculate
unbiased rates and to make comparisons between different groups of immigrants or with the
native population.
5. Conclusions
Even if barriers in access to health services have been observed by several authors and these
barriers could decrease the probability of disease reporting, almost all quantitative evidence shows
a lower probability of under-reporting infectious diseases in migrants than in native populations.
These conclusions are counterintuitive because public health experts expect to know more on disease
occurrence among native populations in their countries than in migrants. When interpreting available
data from infectious disease surveillances, public health operators should consider that figures on
disease occurrence in migrants are probably closer to the real occurrence than the same figures for the
native population.
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